James E. Akers

Technologies in use and on the horizon could change aseptic processing in ways that seemed inconceivable years ago but approaches to aseptic process validation still need to move beyond their 1970s roots.

Isolators offer a safety and economic advantage for next-generation regenerative medicine products.